HRID 348776As reactant
84290-27-7O=Cc1c(O)cccc1OCc1ccc(C(=O)O)cc1XEDONBRPTABQFB-UHFFFAOYSA-NTucaresol has been used in trials studying the treatment of HIV Infections.
84290-27-7DTXSID70233247CHEMBL2104482Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesTucaresol is an orally bioavailable immunopotentiatory drug that show to enhance T-helper-cell activity, with the induction of increased IL-2 and IFN-γ levels in mice and humans. Tucaresol has anti-HIV effect[1].